ISR — ISR Immune System Regulation Holding AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for ISR Immune System Regulation Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 32.3 | 22 | 38.8 | 53.7 | 0.253 |
| Net Total Receivables | 0.97 | 1.01 | 1.16 | 3.1 | 5 |
| Prepaid Expenses | |||||
| Total Current Assets | 33.3 | 23.1 | 40.1 | 57 | 5.87 |
| Net Property, Plant And Equipment | 0.653 | 0.466 | 0 | 0 | — |
| Total Assets | 33.9 | 23.6 | 40.1 | 57 | 5.87 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.6 | 24.5 | 4.38 | 17.4 | 179 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 5.88 | 24.6 | 4.38 | 18.4 | 180 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 28 | -1.03 | 35.7 | 38.5 | -175 |
| Total Liabilities & Shareholders' Equity | 33.9 | 23.6 | 40.1 | 57 | 5.87 |
| Total Common Shares Outstanding |